Literature DB >> 27300696

CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061.

Iris Chen1, Wei Huang2, Matthew B Connor3, Arne Frantzell2, Vanessa Cummings1, Geetha G Beauchamp3, Sam Griffith4, Sheldon D Fields5, Hyman M Scott6, Steven Shoptaw7, Carlos Del Rio8, Manya Magnus9, Sharon Mannheimer10, Hong-Van Tieu11, Darrell P Wheeler12, Kenneth H Mayer13,14,15, Beryl A Koblin11, Susan H Eshleman1.   

Abstract

OBJECTIVE: To evaluate factors associated with HIV tropism among Black men who have sex with men (MSM) in the United States enrolled in a clinical study (HIV Prevention Trials Network 061).
METHODS: HIV tropism was analyzed using a phenotypic assay (Trofile assay, Monogram Biosciences). Samples were analyzed from 43 men who were HIV infected at enrollment and reported either exclusive insertive intercourse or exclusive receptive intercourse; samples were also analyzed from 20 men who were HIV uninfected at enrollment and seroconverted during the study. Clonal analysis of individual viral variants was performed for seroconverters who had dual/mixed (DM) viruses.
RESULTS: DM viruses were detected in samples from 11 (26%) of the 43 HIV-infected men analyzed at the enrollment visit; HIV tropism did not differ between those reporting exclusive insertive vs receptive intercourse. DM viruses were also detected in five (25%) of the 20 seroconverters. DM viruses were associated with lower CD4 cell counts. Seroconverters with DM viruses had dual-tropic viruses only or mixed populations of CCR5- and dual-tropic viruses.
CONCLUSIONS: DM viruses were frequently detected among Black MSM in this study, including seroconverters. Further studies are needed to understand factors driving transmission and selection of CXCR4- and dual-tropic viruses among Black MSM.

Entities:  

Keywords:  Black; CXCR4; Dual-tropic; Dual/mixed; HIV; Men who have sex with men; Tropism

Mesh:

Substances:

Year:  2016        PMID: 27300696      PMCID: PMC5003405          DOI: 10.1080/15284336.2016.1180771

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  28 in total

1.  Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission.

Authors:  Kristen Chalmet; Kenny Dauwe; Lander Foquet; Franky Baatz; Carole Seguin-Devaux; Bea Van Der Gucht; Dirk Vogelaers; Linos Vandekerckhove; Jean Plum; Chris Verhofstede
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Bioinformatics prediction of HIV coreceptor usage.

Authors:  Thomas Lengauer; Oliver Sander; Saleta Sierra; Alexander Thielen; Rolf Kaiser
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

3.  Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.

Authors:  Beatrice A Chen; Lori Panther; Mark A Marzinke; Craig W Hendrix; Craig J Hoesley; Ariane van der Straten; Marla J Husnik; Lydia Soto-Torres; Annalene Nel; Sherri Johnson; Nicola Richardson-Harman; Lorna K Rabe; Charlene S Dezzutti
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

4.  X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain.

Authors:  Rocío Sierra-Enguita; Carmen Rodriguez; Antonio Aguilera; Felix Gutierrez; Jose M Eiros; Estrella Caballero; Mariana Lapaz; Vicente Soriano; Jorge del Romero; Carmen de Mendoza
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

5.  Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.

Authors:  Jori Symons; Steven F L van Lelyveld; Andy I M Hoepelman; Petra M van Ham; Dorien de Jong; Annemarie M J Wensing; Monique Nijhuis
Journal:  J Antimicrob Chemother       Date:  2011-01-28       Impact factor: 5.790

6.  Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors.

Authors:  Annette Audigé; Patrick Taffé; Martin Rickenbach; Manuel Battegay; Pietro Vernazza; David Nadal; Roberto F Speck
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

7.  Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters.

Authors:  Carmen de Mendoza; Kurt Van Baelen; Eva Poveda; Evelien Rondelez; Natalia Zahonero; Lieven Stuyver; Carolina Garrido; Jorge Villacian; Vincent Soriano
Journal:  J Acquir Immune Defic Syndr       Date:  2008-07-01       Impact factor: 3.731

8.  Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities.

Authors:  Sharon B Mannheimer; Lei Wang; Leo Wilton; Hong Van Tieu; Carlos Del Rio; Susan Buchbinder; Sheldon Fields; Sara Glick; Matthew B Connor; Vanessa Cummings; Susan H Eshleman; Beryl Koblin; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

9.  Env sequence determinants in CXCR4-using human immunodeficiency virus type-1 subtype C.

Authors:  Nina H Lin; Carlos Becerril; Francoise Giguel; Vladimir Novitsky; Sikhulile Moyo; Joseph Makhema; Myron Essex; Shahin Lockman; Daniel R Kuritzkes; Manish Sagar
Journal:  Virology       Date:  2012-09-03       Impact factor: 3.616

Review 10.  Clinical significance of HIV-1 coreceptor usage.

Authors:  Hanneke Schuitemaker; Angélique B van 't Wout; Paolo Lusso
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.